Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?
JN O'Donnell, V Putra, TP Lodise - … : The Journal of Human …, 2021 - Wiley Online Library
This review critically appraises the published microbiologic and clinical data on the
treatment of patients with carbapenem‐resistant Acinetobacter baumannii infections …
treatment of patients with carbapenem‐resistant Acinetobacter baumannii infections …
Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc …
C Longshaw, A Santerre Henriksen… - Microbiology …, 2023 - Am Soc Microbiol
This study aimed to determine the proportion of heteroresistance in carbapenem-resistant
Acinetobacter calcoaceticus-baumannii complex (CRAB) isolates in the cefiderocol arm of …
Acinetobacter calcoaceticus-baumannii complex (CRAB) isolates in the cefiderocol arm of …
Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections
KA Parsels, KA Mastro, JM Steele… - Journal of …, 2021 - academic.oup.com
Cefiderocol is a novel siderophore cephalosporin that forms a complex with extracellular
free ferric iron, which leads to transportation across the outer cell membrane to exert its …
free ferric iron, which leads to transportation across the outer cell membrane to exert its …
Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene …
PJ Simner, HH Mostafa, Y Bergman… - Clinical Infectious …, 2022 - academic.oup.com
Background As cefiderocol is increasingly being prescribed in clinical practice, it is critical
that we understand key mechanisms contributing to acquired resistance to this agent …
that we understand key mechanisms contributing to acquired resistance to this agent …
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft …
X Zhao, H Huang, H Yuan, Z Yuan… - Journal of Antimicrobial …, 2022 - academic.oup.com
Objectives Contezolid is a novel oxazolidinone antibacterial agent for managing infections
caused by aerobic and anaerobic Gram-positive bacteria including methicillin-resistant …
caused by aerobic and anaerobic Gram-positive bacteria including methicillin-resistant …
Antibiotic resistance during and beyond COVID-19
DM Livermore - JAC-antimicrobial Resistance, 2021 - academic.oup.com
Antibiotics underpin the 'modern medicine'that has increased life expectancy, leading to
societies with sizeable vulnerable elderly populations who have suffered disproportionately …
societies with sizeable vulnerable elderly populations who have suffered disproportionately …
Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists
JC Abdul-Mutakabbir, NC Griffith, RK Shields… - Infectious diseases and …, 2021 - Springer
The purpose of this narrative review is to bring together the most recent epidemiologic,
preclinical, and clinical findings to offer our perspective on best practices for managing …
preclinical, and clinical findings to offer our perspective on best practices for managing …
Cefiderocol treatment for patients with multidrug-and carbapenem-resistant Pseudomonas aeruginosa infections in the compassionate use program
Cefiderocol is an option for infections caused by multidrug-resistant Pseudomonas
aeruginosa, but its in vitro activity against these isolates and its clinical effectiveness for …
aeruginosa, but its in vitro activity against these isolates and its clinical effectiveness for …
Novel antimicrobial agents for gram-negative pathogens
M Karvouniaris, MP Almyroudi, MH Abdul-Aziz, S Blot… - Antibiotics, 2023 - mdpi.com
Gram-negative bacterial resistance to antimicrobials has had an exponential increase at a
global level during the last decades and represent an everyday challenge, especially for the …
global level during the last decades and represent an everyday challenge, especially for the …
Nanomaterials for the diagnosis and treatment of urinary tract infections
The diagnosis and treatment of urinary tract infections (UTIs) remain challenging due to the
lack of convenient assessment techniques and to the resistance to conventional …
lack of convenient assessment techniques and to the resistance to conventional …